Author:
Krutsinger Dustin C.,McMahon Jacqueline,Stephens-Shields Alisa J.,Bayes Brian,Brooks Steven,Hitsman Brian L.,Lubitz Su Fen,Reyes Celine,Schnoll Robert A.,Ryan Greysen S.,Mercede Ashley,Patel Mitesh S.,Reale Catherine,Barg Fran,Karlawish Jason,Polsky Daniel,Volpp Kevin G.,Halpern Scott D.
Funder
National Cancer Institute
Subject
Pharmacology (medical),General Medicine
Reference64 articles.
1. Adult cancer clinical trials that fail to complete: an epidemic?;Stensland;J Natl Cancer Inst,2014
2. Early termination of cardiovascular trials as a consequence of poor accrual: analysis of ClinicalTrials.gov 2006–2015;Baldi;BMJ Open,2017
3. Unsuccessful trial accrual and human subjects protections: an empirical analysis of recently closed trials;Carlisle;Clin Trials,2015
4. Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials;Schroen;Clin Trials,2010
5. Institute of Medicine Committee on Cancer Clinical, T. and N.C.I.C.G.P. the, in A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program, S.J. Nass, H.L. Moses, and J. Mendelsohn, Editors. 2010, National Academies Press (US) Copyright 2010 By the National Academy of Sciences. All rights reserved, Washington (DC)
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献